Reanalyses of Randomized Clinical Trial Data

被引:127
|
作者
Ebrahim, Shanil [1 ,2 ,3 ,4 ]
Sohani, Zahra N. [2 ,5 ]
Montoya, Luis [6 ]
Agarwal, Arnav [7 ]
Thorlund, Kristian [1 ,2 ]
Mills, Edward J. [1 ,2 ,8 ]
Ioannidis, John P. A. [1 ,9 ,10 ,11 ]
机构
[1] Stanford Univ, Dept Med, Stanford Prevent Res Ctr, Stanford, CA 94305 USA
[2] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada
[3] McMaster Univ, Dept Anesthesia, Hamilton, ON L8S 4L8, Canada
[4] Hosp Sick Children, Dept Anaesthesia & Pain Med, Toronto, ON M5G 1X8, Canada
[5] McMaster Univ, Populat Genom Program, Hamilton, ON L8S 4L8, Canada
[6] Univ Hlth Network, Toronto, ON, Canada
[7] McMaster Univ, Fac Hlth Sci, Hamilton, ON L8S 4L8, Canada
[8] Univ Ottawa, Fac Hlth Sci, Ottawa, ON, Canada
[9] Stanford Univ, Sch Med, Dept Hlth Res & Policy, Stanford, CA 94305 USA
[10] Stanford Univ, Sch Humanities & Sci, Dept Stat, Stanford, CA 94305 USA
[11] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, Stanford, CA 94305 USA
来源
基金
加拿大健康研究院;
关键词
PERIPHERAL NEUROPATHY; EFFICACY CRITERIA; NATIONAL-SURVEY; ACUPUNCTURE; GENETICS; SCIENCE; DISEASE; MODEL;
D O I
10.1001/jama.2014.9646
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
IMPORTANCE Reanalyses of randomized clinical trial (RCT) data may help the scientific community assess the validity of reported trial results. OBJECTIVES To identify published reanalyses of RCT data, to characterize methodological and other differences between the original trial and reanalysis, to evaluate the independence of authors performing the reanalyses, and to assess whether the reanalysis changed interpretations from the original article about the types or numbers of patients who should be treated. DESIGN We completed an electronic search of MEDLINE from inception to March 9, 2014, to identify all published studies that completed a reanalysis of individual patient data from previously published RCTs addressing the same hypothesis as the original RCT. Four data extractors independently screened articles and extracted data. MAIN OUTCOMES AND MEASURES Changes in direction and magnitude of treatment effect, statistical significance, and interpretation about the types or numbers of patients who should be treated. RESULTS We identified 37 eligible reanalyses in 36 published articles, 5 of which were performed by entirely independent authors (2 based on publicly available data and 2 on data that were provided on request; data availability was unclear for 1). Reanalyses differed most commonly in statistical or analytical approaches (n = 18) and in definitions or measurements of the outcome of interest (n = 12). Four reanalyses changed the direction and 2 changed the magnitude of treatment effect, whereas 4 led to changes in statistical significance of findings. Thirteen reanalyses (35%) led to interpretations different from that of the original article, 3 (8%) showing that different patients should be treated; 1 (3%), that fewer patients should be treated; and 9 (24%), that more patients should be treated. CONCLUSIONS AND RELEVANCE A small number of reanalyses of RCTs have been published to date. Only a few were conducted by entirely independent authors. Thirty-five percent of published reanalyses led to changes in findings that implied conclusions different from those of the original article about the types and number of patients who should be treated.
引用
收藏
页码:1024 / 1032
页数:9
相关论文
共 50 条
  • [31] Pioglitazone and Risk for Bone Fracture: Safety Data From a Randomized Clinical Trial
    Viscoli, Catherine M.
    Inzucchi, Silvio E.
    Young, Lawrence H.
    Insogna, Karl L.
    Conwit, Robin
    Furie, Karen L.
    Gorman, Mark
    Kelly, Michael A.
    Lovejoy, Anne M.
    Kernan, Walter N.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (03): : 914 - 922
  • [32] Generalized growth curve models for longitudinal data in application to a randomized clinical trial
    Andrews, Nichole
    Cho, Hyunkeun Ryan
    JOURNAL OF THE KOREAN STATISTICAL SOCIETY, 2019, 48 (01) : 40 - 49
  • [33] Measurement Reactivity in a Randomized Clinical Trial Using Self-Reported Data
    Capellan, Jahaira
    Wilde, Mary H.
    Zhang, Feng
    JOURNAL OF NURSING SCHOLARSHIP, 2017, 49 (01) : 111 - 119
  • [34] Cardiorenal syndrome and the association with fitness: Data from a telerehabilitation randomized clinical trial
    Langlo, Knut Asbjorn Rise
    Lundgren, Kari Margrethe
    Zanaboni, Paolo
    Mo, Rune
    Ellingsen, Oyvind
    Hallan, Stein Ivar
    Aksetoy, Inger-Lise Aamot
    Dalen, Havard
    ESC HEART FAILURE, 2022, 9 (04): : 2215 - 2224
  • [35] Validity of clinical body weight measures as substitutes for missing data in a randomized trial
    Arterburn, David
    Ichikawa, Laura
    Ludman, Evette J.
    Operskalski, Belinda
    Linde, Jennifer A.
    Anderson, Emily
    Rohde, Paul
    Jeffery, Robert W.
    Simon, Greg E.
    OBESITY RESEARCH & CLINICAL PRACTICE, 2008, 2 (04) : 277 - 281
  • [36] HOW MUCH DATA SHOULD WE COLLECT IN A RANDOMIZED CLINICAL-TRIAL
    VERTER, J
    STATISTICS IN MEDICINE, 1990, 9 (1-2) : 103 - 113
  • [37] Generalized growth curve models for longitudinal data in application to a randomized clinical trial
    Nichole Andrews
    Hyunkeun Ryan Cho
    Journal of the Korean Statistical Society, 2019, 48 : 40 - 49
  • [38] A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker
    J. F. Dhainaut
    W. L. Macias
    D. R. Nelson
    Intensive Care Medicine, 2004, 30 (5) : 995 - 995
  • [39] A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker
    J. Carlet
    Intensive Care Medicine, 2004, 30 : 994 - 994
  • [40] A blind clinical evaluation committee should, in theory, make data of a randomized clinical trial stronger, not weaker
    Dhainaut, JF
    Macias, WL
    Nelson, DR
    INTENSIVE CARE MEDICINE, 2004, 30 (05) : 995 - 995